cytarabine

Generic: cytarabine

Labeler: hospira, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cytarabine
Generic Name cytarabine
Labeler hospira, inc.
Dosage Form INJECTION, SOLUTION
Routes
INTRATHECAL INTRAVENOUS SUBCUTANEOUS
Active Ingredients

cytarabine 20 mg/mL

Manufacturer
Hospira, Inc.

Identifiers & Regulatory

Product NDC 61703-305
Product ID 61703-305_d8c6ffbd-a0d9-4094-a6ea-d94cb93c5c2d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA071868
Listing Expiration 2026-12-31
Marketing Start 1990-06-04

Pharmacologic Class

Established (EPC)
nucleoside metabolic inhibitor [epc]
Mechanism of Action
nucleic acid synthesis inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 61703305
Hyphenated Format 61703-305

Supplemental Identifiers

RxCUI
1731355
UNII
04079A1RDZ
NUI
N0000000233 N0000175595

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cytarabine (source: ndc)
Generic Name cytarabine (source: ndc)
Application Number ANDA071868 (source: ndc)
Routes
INTRATHECAL INTRAVENOUS SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 20 mg/mL
source: ndc
Packaging
  • 5 VIAL, SINGLE-DOSE in 1 CARTON (61703-305-38) / 5 mL in 1 VIAL, SINGLE-DOSE (61703-305-58)
source: ndc

Packages (1)

61703-305-38 5 VIAL, SINGLE-DOSE in 1 CARTON (61703-305-38) / 5 mL in 1 VIAL, SINGLE-DOSE (61703-305-58)

Ingredients (1)

cytarabine (20 mg/mL)

Linked Drug Pages (1)

Cytarabine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRATHECAL", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "d8c6ffbd-a0d9-4094-a6ea-d94cb93c5c2d", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["04079A1RDZ"], "rxcui": ["1731355"], "spl_set_id": ["bc2fa221-ea56-48b8-8304-42cd81b8463b"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 VIAL, SINGLE-DOSE in 1 CARTON (61703-305-38)  / 5 mL in 1 VIAL, SINGLE-DOSE (61703-305-58)", "package_ndc": "61703-305-38", "marketing_start_date": "19900604"}], "brand_name": "Cytarabine", "product_id": "61703-305_d8c6ffbd-a0d9-4094-a6ea-d94cb93c5c2d", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "61703-305", "generic_name": "CYTARABINE", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cytarabine", "active_ingredients": [{"name": "CYTARABINE", "strength": "20 mg/mL"}], "application_number": "ANDA071868", "marketing_category": "ANDA", "marketing_start_date": "19900604", "listing_expiration_date": "20261231"}